Articles > Newspapers > International Newspapers, Local Markets A-Lh > AsiaPulse News news wires > June 2009

Article: BUSINESS IN ASIA TODAY - JUNE 12, 2009.

Article from:
AsiaPulse News
Article date:
June 12, 2009
Copyright

Business in Asia on June 12, 2009. A summary prepared by Asia Pulse (http://www.asiapulse.com), the real-time, Asia-based wire with exclusive news, market intelligence and business opportunities:

CHINA'S SHENZHEN NEPTUNUS INTERLONG BIO-TECH TEAMS UP WITH GSK

BEIJING - Shenzhen Netptunus Interlong Bio-Tech Co. Ltd. (SEHK:8329), a Shenzhen-based Chinese drug maker, has inked an agreement to set up a joint venture with GlaxoSmithKline (GSK), the world's second largest pharmaceutical company. The joint venture, to be founded in Shenzhen, will be engaged in R&D, production and sales of influenza vaccine for human use, rabies vaccine and other vaccines for ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: GSK and Interlong Bio-technique to set up vaccine ...
China Business News;  November 21, 2008 ;     700+ words ...GSK and Interlong Bio-technique to set up vaccine JV ... INTERFAX-CHINA - Shenzhen Neptunus Interlong Bio- technique Co. Ltd. has signed ... vaccine joint venture in China, Interlong Bio-technique's parent company announced ...

Article: CHINA'S SHENZHEN NEPTUNUS INTERLONG BIO-TECH TEAMS ...
AsiaPulse News;  June 12, 2009 ;     700+ words ...BEIJING, June 12 Asia Pulse - Shenzhen Netptunus Interlong Bio-Tech Co. Ltd. (SEHK:8329), a Shenzhen-based Chinese drug maker, has inked an agreement to set up a joint venture with ...

Article: UK pharma major GlaxoSmithKline (GSK) is forming a joint venture ...
Chemistry and Industry;  July 13, 2009 ;     700+ words ...UK pharma major GlaxoSmithKline (GSK) is forming a joint venture with China's Shenzhen Neptunus Interlong Bio-Technique to develop and manufacture influenza vaccines for the Chinese market. GSK will hold a 40% stake in the venture ...

Article: JAPAN FURUKAWA-SKY TO HALT ALUMINUM SHEET ROLLING AT NIKKO ...
AsiaPulse News;  June 12, 2009 ;     651 words ... ... aluminum sheet rolling facility at its Nikko plant, in Tochigi Prefecture, by 2013 as ... facility and some other functions at the Nikko plant -- which has a monthly output capacity ... plants. Capacity utilization at the Nikko plant had already fallen to 70 per cent or ...

Article: BRIEFING - ASIA HEALTH - JUNE 12, 2009.
AsiaPulse News;  June 12, 2009 ;     700+ words ... ... same period, according to a stock exchange filing. CHINA'S SHENZHEN NEPTUNUS INTERLONG BIO-TECH TEAMS UP WITH GSK BEIJING - Shenzhen Netptunus Interlong Bio-Tech Co. Ltd. (SEHK:8329), a Shenzhen-based Chinese drug maker, has ...

Article: FIVE COMPANIES APPROVED TO ISSUE SHARES OVERSEAS
AsiaInfo Services;  March 2, 2005 ;     332 words ... ... Manufacturing Corporation of Shanghai, Shenzhen Neptunus Interlong Bio-Tech Holdings Co., Ltd., Beijing Capital Land Ltd ... and the face value per share is CNY1. Shenzhen Neptunus Interlong Bio-Tech Holdings Co., Ltd. has been approved to issue less ...

Article: NEPTUNUS BIOENGINEERING TO SELL 2 SUBSIDIARIES
AsiaInfo Services;  March 3, 2009 ;     349 words ... ... Neptunus Fuyao Pharmaceuticals Co., Ltd. to Shenzhen Neptunus Interlong Bio-Tech Co., Ltd. (SEHK: 8329). Meanwhile, the Hong ... interferon and interleukin to Neptunus Pharmaceutical. Neptunus Interlong Bio-Tech went public on the Stock Exchange of Hong Kong in ...

Article: GSK takes steps to set up flu JV in China.
Pharma Marketletter;  December 1, 2008 ;     650 words ...UK drug giant GlaxoSmithKline has signed an exclusive cooperation agreement with China's Shenzhen Neptunus Interlong Bio-Technique (NIBT) as a preliminary step in forming a joint venture between the two. The accord outlines the proposed terms ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives